CompletedNot Applicable

Innovative Treatments for Neurogenic Dysphagia

Italy110 participantsStarted 2021-06-15

Plain-language summary

This study aims to evaluate different non-invasive and neuromuscular stimulation treatments for neurogenic dysphagia in post-stroke and Parkinson's disease patients. The study is divided into three sub-studies: 1. Unilateral, bihemispheric, or sham transcranial Direct Current Stimulation (tDCS) in post-stroke dysphagia (patients ≥2 weeks from onset). 2. Bihemispheric or sham tDCS in Parkinson's disease-related dysphagia. 3. Neuromuscular stimulation therapy in post-stroke and Parkinson's disease dysphagia.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18-85 years * Diagnosis of post-stroke or Parkinson's disease-related dysphagia * Dysphagia duration ≥ 2 weeks for post-stroke patients and ≥ 6 months for Parkinson's disease patients * Ability to undergo rehabilitation therapy * Written informed consent obtained Exclusion Criteria: * Severe dysphagia requiring Percutaneous Endoscopic Gastrostomy (PEG) feeding for more than 1 year * Non-neurogenic causes of dysphagia * Contraindications to tDCS or NMES * Cognitive impairment affecting compliance with treatment

What they're measuring

Dysphagia Outcome and Severity Scale (DOSS) score

Timeframe: At baseline and 6 weeks post-treatment

Trial details

NCT IDNCT07152899

SponsorIRCCS National Neurological Institute "C. Mondino" Foundation

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-15

View on ClinicalTrials.gov More Stroke, Complication trials